Troxacitabine T17175
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Troxacitabine, a DNA polymerase inhibitor, is potentially used for the treatment of acute myeloid leukemia (AML). In comparison with gemcitabine, troxacitabine was equally active against MiaPaCa and was more efficacious against Panc-01.
CAS nr:
145918-75-8
Purity:
98%
Molecular Weight:
213,19
SMILES:
O=C1N=C(N)C=CN1C2O[C@@H](CO)OC2
Formula:
C8H11N3O4
Pathway:
Others
Target:
Others
